Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-126319

Chief Commercial Officer gave up 3,935 shares (to pay taxes)

  • Chief Commercial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kirby Daniel Gordon · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-10 Exercise or conversion : show line 1 in the form +10,000 164,511 D
2026-11-10 Shares withheld for taxes : show line 2 in the form −3,935 $8.08 $31,795 160,576 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-10 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,000 50,003 D
Loading xslF345X06/tm2629634-1_4seq1.xml…